Oregon Oncology COVID 19

Viewing Page 1 of 1 | Showing Results 1 - 4 of 4

NCI COVID-19 in Cancer Patients Study (NCCAPS): A Longitudinal Natural History Study.

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test...

Gary Goodman, M.D.

The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.

RWF: A Multicenter, Randomized-Controlled Trial to Evaluate the Efficacy and Safety of Antithrombotic Therapy for Prevention of Arterial and Venous Thrombotic Complications in Critically-Ill COVID-19 Patients

This is a multicenter, open-label, 2x2 factorial, randomized-controlled trial in critically-ill patients with novel coronavirus disease 2019...

Jason Wells, M.D.
  • Providence Portland Medical Center

Double-Blind, Randomized, Placebo-Controlled, Adaptive Design, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

The study is a double-blind, randomized, placebo-controlled, adaptive design, multi-center, Phase 3 study to evaluate the efficacy and safety of...

Jason Wells, M.D.
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Remdesivir in Participants with Severely Reduced Kidney Function who are Hospitalized with COVID-19

The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical...

Tobias Pusch, M.D.
  • Alaska Research
  • Providence Portland Medical Center
  • Providence St. Vincent Medical Center
Viewing Page 1 of 1 | Showing Results 1 - 4 of 4